by Eric Christianson | Aug 9, 2026 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
I’m often presented with situations where an elderly patient is experiencing new-onset hallucinations. As a pharmacist, my primary focus is to look at the medication list and identify if any drug could potentially be the culprit. Here’s my list of...
by Eric Christianson | Apr 9, 2025 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Benzodiazepines (BZDs) are FDA-approved for various conditions, such as anxiety, mood disorders, insomnia, and seizures. Although they treat a wide range of conditions, there are many safety concerns including increased risk of falls, cognitive impairment, delirium,...
by Eric Christianson | Jun 26, 2024 | Clinical Pharmacy News and New Drug Updates, Psychiatry and Addiction Medication and Disease State Clinical Pearls
I’ve encountered a significant proportion of patients who are on chronic benzodiazepines. Drug interactions, adverse effects, and other risks to my geriatric patient population are significant when using this class of medication. Benzodiazepine withdrawal is...
